Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.19)
# 440
Out of 4,955 analysts
88
Total ratings
37.93%
Success rate
23.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MYO Myomo | Maintains: Buy | $9.5 → $5 | $1.10 | +356.62% | 6 | Aug 12, 2025 | |
KZIA Kazia Therapeutics | Maintains: Buy | $2 → $13 | $7.00 | +85.71% | 5 | Jul 10, 2025 | |
SENS Senseonics Holdings | Maintains: Buy | $1.1 → $1.4 | $0.44 | +218.18% | 2 | Jul 8, 2025 | |
PSTV Plus Therapeutics | Maintains: Buy | $5.5 → $3 | $0.46 | +552.17% | 12 | Jun 27, 2025 | |
CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $2.33 | +71.67% | 9 | May 19, 2025 | |
CTSO Cytosorbents | Reiterates: Neutral | $1 | $0.93 | +7.49% | 13 | May 15, 2025 | |
VSTM Verastem | Maintains: Buy | $10 → $14 | $8.43 | +66.07% | 14 | May 9, 2025 | |
DWTX Dogwood Therapeutics | Upgrades: Buy | $10 | $4.88 | +104.92% | 1 | Apr 23, 2025 | |
ATEC Alphatec Holdings | Reiterates: Buy | $20 | $15.80 | +26.62% | 12 | Apr 14, 2025 | |
MNPR Monopar Therapeutics | Reiterates: Buy | $40 | $33.00 | +21.21% | 10 | Apr 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $5.19 | +111.95% | 3 | Mar 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $0.96 | +3,025.00% | 1 | Dec 5, 2022 |
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $1.10
Upside: +356.62%
Kazia Therapeutics
Jul 10, 2025
Maintains: Buy
Price Target: $2 → $13
Current: $7.00
Upside: +85.71%
Senseonics Holdings
Jul 8, 2025
Maintains: Buy
Price Target: $1.1 → $1.4
Current: $0.44
Upside: +218.18%
Plus Therapeutics
Jun 27, 2025
Maintains: Buy
Price Target: $5.5 → $3
Current: $0.46
Upside: +552.17%
CASI Pharmaceuticals
May 19, 2025
Reiterates: Buy
Price Target: $4
Current: $2.33
Upside: +71.67%
Cytosorbents
May 15, 2025
Reiterates: Neutral
Price Target: $1
Current: $0.93
Upside: +7.49%
Verastem
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $8.43
Upside: +66.07%
Dogwood Therapeutics
Apr 23, 2025
Upgrades: Buy
Price Target: $10
Current: $4.88
Upside: +104.92%
Alphatec Holdings
Apr 14, 2025
Reiterates: Buy
Price Target: $20
Current: $15.80
Upside: +26.62%
Monopar Therapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $33.00
Upside: +21.21%
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $5.19
Upside: +111.95%
Dec 5, 2022
Initiates: Buy
Price Target: $30
Current: $0.96
Upside: +3,025.00%